Trump’s Pharma Tariffs Would Spare Richest Drugmakers While Punishing Some Small Ones
Health By Rebecca Robbins from NYT Health https://ift.tt/kXwq6rH via IFTTT International Trade and World Market, Drugs (Pharmaceuticals), United States Politics and Government, Prices (Fares, Fees and Rates), Factories and Manufacturing, Biotechnology and Bioengineering Big companies like Novartis say new tariffs won’t hit them. “A win for Pharma,” Wall Street analysts said.